Table 1 Effects of co-treatment of breast cancer cell lines with probenecid and bisphosphonates on the expression of KLF2

13.0** (2.3-60.8)

3.0* (1.2-7.6)

3.1 (0.6-16.0)

32.4** (5.8-198.5)

2.6* (1.0-6.7)

5.1* (0.7-25.6)

1.6 (0.3-10.1)

2.1* (1.0-3.7)

3.5* (0.6-18.8)

4.2 (0.7-35.9)

1.7 (0.7-4.7)

3.4 (0.5-19.2)

2.4 (0.5-15.2)

2.2* (0.9-4.9)

2.4 (0.3-17.3)

6.1* (0.8-31.7)

2.2* (0.9-5.9)

4.8** (0.7-28.4)

5.8* (1.2-33.4)

2.0 (0.8-5.5)

1.4 (0.2-11.4)

36.1** (9.7-141.4)

1.8 (0.8-5.6)

3.2 (0.4-31.1)

1.0 (0.3-5.0)

1.0 (0.8-1.3)

1.3 (0.1-9.4)